Response and toxicity assessments
toxicity, Cancer
ADVERSE EVENT, ADVERSE EVENT, CANCER
Response assessments were done using RECIST version 1.1. Adverse events (AEs) were evaluated every 3 weeks (±1 week) using Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Patients who had received at least one cycle of chemotherapy were included in toxicity assessment. A QoL assessment was conducted at the midpoint and at the completion of the chemotherapy using Functional Assessment of Cancer Therapy-Breast (FACT-B) version 4.0 [